📰 Solid Tumors News
Page 33 - Solid Tumors News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Solid Tumors. Real-time updates on events, politics, business and more.
May 17, 2023
Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) – Stock analysts at Brookline Capital Management boosted their Q2 2023 earnings per share (EPS) estimates for Kura Oncology in a research report issued to clients and investors on Wednesday, May 10th. Brookline Capital Management analyst L. Cann now forecasts that the company will earn ($0.71) per share […]
May 16, 2023
Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) shares gapped down before the market opened on Tuesday . The stock had previously closed at $12.66, but opened at $12.25. Kura Oncology shares last traded at $11.78, with a volume of 29,367 shares trading hands. Analyst Ratings Changes KURA has been the subject of a number of […]
May 16, 2023
The upcoming phase 1/2 EVEREST-1 trial, where the novel CAR T-cell therapy A2B530 will be evaluated in patients with solid tumors, aims to push progress for one-and-done engineered therapies in this space.
May 16, 2023
Understand how a biotech company was able to facilitate clinical development plans to extend its study into China for Phase II component, as quickly...
May 15, 2023
Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) – Equities research analysts at Wedbush cut their Q2 2023 earnings per share estimates for shares of Kura Oncology in a report released on Thursday, May 11th. Wedbush analyst R. Driscoll now anticipates that the company will earn ($0.54) per share for the quarter, down from their prior […]
May 15, 2023
Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) – HC Wainwright upped their Q2 2023 earnings per share (EPS) estimates for shares of Kura Oncology in a report released on Thursday, May 11th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per share of ($0.54) for the quarter, up from their […]
May 15, 2023
Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) – Equities research analysts at Brookline Capital Management upped their Q2 2023 earnings estimates for Kura Oncology in a report released on Wednesday, May 10th. Brookline Capital Management analyst L. Cann now expects that the company will post earnings per share of ($0.71) for the quarter, up from […]
May 13, 2023
Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) – Analysts at Wedbush raised their FY2025 earnings per share (EPS) estimates for shares of Kura Oncology in a research note issued to investors on Thursday, May 11th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of $2.45 per share for the year, up […]
May 13, 2023
Denali Advisors LLC trimmed its holdings in Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) by 41.5% in the fourth quarter, Holdings Channel reports. The fund owned 3,800 shares of the company’s stock after selling 2,700 shares during the period. Denali Advisors LLC’s holdings in Kura Oncology were worth $47,000 at the end of the most […]
May 13, 2023
Denali Advisors LLC lessened its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) by 41.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,800 shares of the company’s stock after selling 2,700 shares during the quarter. Denali Advisors LLC’s holdings […]